Anticoagulation

AHA 24: The OPTION Trial

Oussama M Wazni

TCT 24: The PEERLESS Trial

Dr Wissam A Jaber

Watch time: 6m 16s
ESC 24: The POPular PAUSE TAVI Trial

Dirk-Jan van Ginkel

Watch time: 7m 9s
ESC 24 Hot Line Discussion: The OCEANIC-AF Trial

Manesh R Patel, Harriette Van Spall

Watch time: 8m 47s
ESC 24: EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD

Gi-Byoung Nam, Min Soo Cho

Watch time: 6m 48s

Harriette Van Spall, Stefan James

Fatin Fazrina Roslan , Yuexin Yu , Nurul Ain Nasim Mohd Yusof , et al

Read time: 5m

Byoung Geol Choi , Seung-Woon Rha , Se Yeon Choi , et al

Read time: 5m

Shunsuke Kiuchi , Shinji Hisatake , Yoshiki Murakami , et al

Read time: 5m

Ubonwan Sapoo , Nuengruthai Phunpha , Patipan Pusopa , et al

Read time: 5m

Apisara Lohachatinante , Nuttanun Kittikunkanyakit , Sayamon Sukkha , et al

Read time: 5m

Tobias Geisler

Read time: 3m 13s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Kerry Layne , Albert Ferro

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Julia Sikorska , James Uprichard

Mario Petretta , Pierluigi Costanzo , Alberto Cuocolo

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Frédéric Michard

Yugo Yamashita

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff

Watch time: 10m 36s

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof

Watch time: 3m 42s

Yugo Yamashita

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan

Watch time: 17m 13s

Media

TCT 24: The PEERLESS Trial

Dr Wissam A Jaber

Watch time: 6m 16s
AHA 24: The OPTION Trial

Oussama M Wazni

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer

Watch time: 1h 5m 20s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen

Watch time: 28m 9s

Harriette Van Spall, Stefan James

ESC 24: The POPular PAUSE TAVI Trial

Dirk-Jan van Ginkel

Watch time: 7m 9s
ESC 24: EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD

Gi-Byoung Nam, Min Soo Cho

Watch time: 6m 48s
ESC 24 Hot Line Discussion: The OCEANIC-AF Trial

Manesh R Patel, Harriette Van Spall

Watch time: 8m 47s

Pablo Avanzas, Román Freixa Pamias, Antoni Martínez-Rubio, et al

Watch time: 28m 4s

Articles

New Anticoagulants as an Alternative to Aspirin in Atrial Fibrillation

Raffaele De Caterina

,

Citation:

European Cardiology 2011;7(3):196–8

DOI:

https://doi.org/10.15420/ecr.2011.7.3.196
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1225
  • Downloads: Downloads 3

New Drugs for Thromboembolic Prevention in Atrial Fibrillation

Jose L Merino

,

José López-Sendón

,

Citation:

European Cardiology 2010;6(4):64–9

DOI:

https://doi.org/10.15420/ecr.2010.6.4.64
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 667
  • Downloads: Downloads 5

New Antiplatelet Drugs in Perspective

Diego Penela

,

Maríbel Diaz-Ricart

,

Magda Heras

,

Citation:

European Cardiology 2011;7(3):216–9

DOI:

https://doi.org/10.15420/ecr.2011.7.3.216
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1083
  • Downloads: Downloads 4

Stroke Prevention in Atrial Fibrillation - The Unmet Need and Morbidity Burden

A John Camm

,

Citation:

European Cardiology 2011;7(3):187–95

DOI:

https://doi.org/10.15420/ecr.2011.7.3.187
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1660
  • Downloads: Downloads 10
  • Citations: 1